Rebif (interferon beta-1a) is a prescription drug used to treat types of multiple sclerosis. Rebif can cause side effects that range from mild to serious. Examples ...
- New Formulation of Rebif(R) Designed to Improve Injection Tolerability Merck Serono, a division of Merck KGaA, announced today that the European Commission has ...
The FDA has approved Rebif Rebidose, a single-use auto-injector prefilled with EMD Serono and Pfizer's ($PFE) interferon beta-1a, for the treatment of relapsing forms ...
Serono SA released impressive 24-week data from its 677-patient, head-to-head study of its product Rebif vs. Biogen Inc. s Avonex in patients with relapsing-remitting multiple sclerosis, and is ...
Rebif (interferon beta-1a) is a prescription drug used to treat some types of multiple sclerosis (MS). Rebif may be safe to use while pregnant or breastfeeding. Keep ...
Merck KGaA has been striking deals and pushing R&D in a bid to revive its slumping drug portfolio. But the company's recent efforts aren't bearing fruit--at least not yet. On Tuesday, the German ...
DARMSTADT, Germany, October 18, 2017/PRNewswire/. Merck, a leading science and technology company, today announced that data for approved and investigational multiple sclerosis (MS) treatments, ...
On September 20, the European Commission approved 30- and 45-mg strengths of oseltamivir phosphate capsules (Tamiflu, Hoffmann-La Roche Ltd) for the treatment and prevention of influenza types A and B ...
The US Food and Drug Administration has approved a single-use autoinjector (Rebidose, EMD Serono Inc./Pfizer Inc) for self-injection of interferon beta-1a (Rebif) in the treatment of relapsing forms ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback